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Abstract
Background: Isotonic saline has been proposed as a safer alternative to traditional hypotonic solutions for
intravenous (IV) maintenance fluids to prevent hyponatremia. However, the optimal tonicity of maintenance
intravenous fluids in hospitalized children has not been determined. The objective of this study was to estimate
and compare the rates of change in serum sodium ([Na]) for patients administered either hypotonic or isotonic IV
fluids for maintenance needs.
Methods: This was a masked controlled trial. Randomization was stratified by admission type: medical patients and
post-operative surgical patients, aged 3 months to 18 years, who required IV fluids for at least 8 hours. Patients
were randomized to receive either 0.45% or 0.9% saline in 5.0% dextrose. Treating physicians used the study fluid
for maintenance; infusion rate and the use of additional fluids were left to their discretion.
Results: Sixteen children were randomized to 0.9% saline and 21 to 0.45% saline. Baseline characteristics, duration
(average of 12 hours) and rate of study fluid infusion, and the volume of additional isotonic fluids given were
similar for the two groups. [Na] increased significantly in the 0.9% group (+0.20 mmol/L/h [IQR +0.03, +0.4]; P =
0.02) and increased, but not significantly, in the 0.45% group (+0.08 mmol/L/h [IQR -0.15, +0.16]; P = 0.07). The rate
of change and absolute change in serum [Na] did not differ significantly between groups.
Conclusions: When administered at the appropriate maintenance rate and accompanied by adequate volume
expansion with isotonic fluids, 0.45% saline did not result in a drop in serum sodium during the first 12 hours of
fluid therapy in children without severe baseline hyponatremia. Confirmation in a larger study is strongly
recommended.
Clinical Trial Registration Number: NCT00457873 (http://www.clinicaltrials.gov/)
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Background
For almost half a century, pediatricians have ordered
“maintenance” intravenous (IV) fluids for children
according to the guidelines set out by Holliday and Segar:
100 cc/kg/day for the first 10 kg, plus 50 cc/kg/day for
the next 10 kg, plus 20 cc/kg/day for each remaining
kilogram [1]. Based on these recommendations for water
intake, and on the estimated daily sodium and potassium
needs of 3 milliequivalents and 2 milliequivalents per
100 kcal per day respectively, a hypotonic solution (0.2%
saline) was recommended.
The wisdom of this approach to IV maintenance fluid
therapy has been questioned recently [2-9]. Several
authors have argued that administration of hypotonic
fluids to hospitalized children - many of whom have a
non-osmotic stimulus for anti-diuretic hormone (ADH)
secretion - may lead to clinically important hyponatremia
[10-13]. Iatrogenic hyponatremia has been the reported
cause of neurological injury or death in more than 50
cases [13-18]. In many of these cases, fluids were admi-
nistered at rates well above those typically recommended
for maintenance [19]- a practice that has since been
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any medium, provided the original work is properly cited.identified as a risk factor for hyponatremia [10]. The like-
lihood and severity of complications depend on both the
rate of fall in serum sodium concentration [Na] and the
absolute [Na] [20].
Concerns regarding hyponatremia have led some
authors to recommend using isotonic saline as the routine
maintenance solution for hospitalized patients, reserving
hypotonic fluids for exceptional situations [9,19,21,22].
Isotonic saline administration may result in an increase in
serum [Na] and/or chloride, [23-25] but has not been
shown to increase the risk for hypernatremia [26]. Six
randomized trials have demonstrated significantly greater
drops in [Na] among patient receiving hypotonic solutions
compared with those receiving isotonic solutions
[25,27-31]. However, these trials may not be generalizable
to the general population of children requiring mainte-
nance IV fluids. Two studies were limited to critically ill
children [27,29]. Two trials in surgical patients included
the intra-operative period in addition to the immediate
post-operative period [28,30]; the intraoperative period
may be physiologically distinct from the post-operative
period, and may be better considered separately. Two of
these trials compared 0.9% saline with 0.18% saline. This
solution is rarely used in practice today [27,31]. In fact the
United Kingdom National Patient Safety Agency recom-
mended removal of 0.18% saline from hospital stock in
2007, to reduce the risk of iatrogenic hyponatremia [32].
An additional trial focused on choice of fluid for volume
expansion, rather than for maintenance needs: Neville
compared 0.9% to 0.45% saline for rapid rehydration of
children with gastroenteritis [25]. However, a fall in [Na]
is a predictable outcome if hypotonic fluid is administered
to volume depleted children. Hypotonic solutions are not
recommended for volume expansion –only for mainte-
nance; isotonic solutions are suggested for volume reple-
tion [8,32].
Although the best choice of solution for IV maintenance
needs has not yet been defined, many clinicians, including
those at our institution, commonly prescribe 0.45% saline
as a sort of ‘compromise’ between the traditional 0.18%
saline and a complete switch to isotonic fluids. Therefore,
we chose to compare 0.9% saline in 5.0% dextrose to
0.45% saline in 5.0% dextrose (subsequently referred to as
0.9% and 0.45% saline, respectively). We will refer to 0.9%
saline in 5% dextrose as ‘isotonic’ and 0.45% saline in 5%
dextrose as ‘hypotonic’, as per convention. It should be
recognized that both of these solutions are in fact hyper-
tonic to plasma. However, because dextrose is metabolized
quickly after infusion, these solutions are effectively iso-
tonic (0.9%) and hypotonic (0.45%). We hypothesized that
serum [Na] would fall among children receiving 0.45%
saline and remain stable or increase among children
receiving isotonic fluids. The primary aim of this study
was to estimate the rate of change in [Na] for patients
administered each of hypotonic (0.45% saline) and isotonic
(0.9% saline) IV fluids for maintenance needs, and to com-
pare these rates. Rate of change in [Na] was selected as the
primary outcome to allow ‘standardization’ of changes in
[Na] to a fixed time interval (since the interval between
baseline and exit [Na] was not the same for all partici-
pants). The absolute change in serum [Na], and the pro-
portions with a decrease in [Na], hyponatremia ([Na] <
136 mmol/L), hypernatremia ([Na] > 145 mmol/L), hyper-
tension, and adverse events related to hyponatremia were
also considered.
Methods
Setting and Subjects
This prospective, double-blind, randomized controlled
trial was conducted at the Montreal Children’s Hospital, a
tertiary care pediatric hospital. Two populations of chil-
dren between 3 months and 18 years of age were
recruited: children with medical illnesses admitted via the
emergency department (medical), and children admitted
following elective surgery (surgical). Only those requiring
at least 8 hours of IV fluids were eligible. Exclusion criteria
included a baseline serum [Na] of less than 133 or greater
than 145 mmol/L, renal disease, cardiac dysfunction, pre-
existing hypertension, diuretic use, edema, known adrenal
dysfunction, and acute or severe chronic neurological ill-
ness. Children with neurological illnesses were excluded
for safety reasons (high risk of non-physiologic ADH
secretion, and difficulty in assessing changes in neurologi-
cal status).
Power considerations
A retrospective chart review of hospitalized children simi-
lar to those included in this trial indicated that the stan-
dard deviation for the rate of change in [Na] among
patients administered hypotonic IV fluids was 0.29 mmol/
L/h. This estimate was based, of necessity, on the change
in [Na] observed among children in whom [Na] was mea-
sured at baseline and repeated at least once during IV
fluid administration; both baseline and follow-up [Na]
were obtained in only 20% of children receiving IV fluids.
We planned to enroll 25 subjects per group, giving us 80%
power to detect a difference of 0.21 mmol/L/h between
groups with a one-sided test, setting alpha at 0.05. A one-
sided test was used since it was felt to be physiologically
very unlikely that the 0.9% saline group would experience
a larger drop (or smaller rise) in [Na] than the 0.45% saline
group. This number also gave us 80% power to detect a
change of at least 0.17 mmol/L/hr in each group, with a
two-sided test.
Intervention
Eligible children were invited to participate if they were
expected to receive maintenance IV fluids for at least 8
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0.9% saline in 5.0% dextrose or 0.45% saline in 5.0%
dextrose. Solution bags were covered with an opaque
plastic covering by the pharmacist. Participants, the
treating team and the research team were blinded to the
contents of the solution bags.
Randomization was stratified by admission type (medi-
cal vs. surgical) and carried out in blocks of six using a
computerized random number generator. Baseline serum
[Na] was drawn prior to starting study fluid. In medical
patients, this was done when the IV catheter was
inserted; surgical patients had their blood drawn upon
completion of the surgical procedure. The rate of infu-
sion of study fluid, use of fluid boluses or additional IV
fluids, and addition of potassium to solutions were left to
the discretion of the treating physicians. Treating physi-
cians were informed that the study fluid was either 0.9%
or 0.45% saline in 5% dextrose, and advised to prescribe
it as they would normally prescribe maintenance fluids.
Oral fluids were not restricted and were considered to be
composed of free water. Serum [Na] was repeated
approximately 12 hours (minimum 8; maximum 18
hours) after the beginning of the infusion, at which point
the study ended. Serum [Na] was measured using indirect
potentiometry using the Beckman Coulter DxC analyzer,
which has a range of [Na] detection between 100-200
mmol/L and a coefficient of variation of 1%.
Monitoring
All participants received routine in-patient nursing care,
with vital signs including blood pressure monitored at
least every 4 hours. Nurses also monitored for possible
adverse events including symptoms potentially associated
with hyponatremia (vomiting, change in level of con-
sciousness, headache) or volume overload (edema,
respiratory distress). All fluid intake during the study
interval, including oral, was recorded.
Statistical Analysis
The rate of change in serum [Na] was calculated as (exit
[Na] - baseline [Na]) divided by the number of hours
between baseline and exit blood draws. The rate of main-
tenance fluid administratio nw a se x p r e s s e da sap e r c e n -
tage of the standard recommended rate [1]. The volume
of electrolyte-free water received during the study inter-
val was expressed as a percent of the total fluid volume
received, as described previously [10].
Because the rate of change in [Na], and absolute
change in [Na], were not normally distributed, the med-
ians were compared using the Wilcoxon rank sum test,
and difference from zero was tested using the Wilcoxon
signed rank test. Categorical variables were compared
with chi-square. A P-value < 0.05 was considered
significant. All statistical analyses were performed using
Stata/SE 10.0 (College Station, Texas).
Ethics approval
The study was approved by the institutional Research
Ethics Board. Written informed consent was obtained
from parents or guardians for all participants and assent
was obtained from children over 7 years of age if
appropriate.
Results
As illustrated in Figure 1, 12 of the 25 medical patients
a n d2 5o ft h e3 4s u r g i c a lp a t i e n t sw h oe n r o l l e dc o m -
pleted the study. No exit [Na] was obtained for patients
who did not complete.
Participant characteristics
Characteristics of children receiving 0.9% saline (n = 16)
were similar to those receiving 0.45% saline (n = 21)
w i t hr e s p e c tt oa g e ,s e x ,d i a g n o s i s ,a n db a s e l i n e[ N a ]
(Table 1).
Compared with participants who completed the study,
children who refused participation, or who were
excluded after randomization were younger (median age
4.2 (IQR 1.3, 10.9) years), more likely to be male (60%),
and more likely to have a medical, rather than surgical,
condition (57%).
Fluids administered
The duration and rate of study fluid administration, as
well as the volume of other isotonic fluids received dur-
ing the study period were similar for the two treatment
groups (Table 2).
The majority of participants received supplemental
isotonic fluids in addition to the study fluid. Most of
this supplemental fluid was administered as boluses, but
some surgical patients received infusions of isotonic
fluid in the interval between the baseline blood draw
and start of study fluid.
Changes in serum [Na]
On average, [Na] increased in both treatment groups
(Table 2). However, the rate of change in [Na] was signif-
icantly different from zero only for the 0.9% group (+0.20
mmol/L/h [IQR 0.03, 0.4]; P = 0.02). For the 0.45%
group, [Na] increased by +0.08 mmol/L/h [IQR -0.15,
0.16], which was not significantly different from zero
(P = 0.07). The rate of change in [Na] did not differ sig-
nificantly between treatment groups. The absolute
change in [Na] was greater for the 0.9% saline group
(+3.0 mmol/L [IQR 0.5, 4.5]) compared with the 0.45%
saline group (+1.0 mmol/L [IQR 0.0, 2.0]), however, this
difference was not statistically significant.
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participants with respect to both direction and rate of
change in [Na]. Twenty-four percent (5/21) of the
patients in the 0.45% saline group experienced a drop in
serum [Na], compared with 19% (3/16) of those in the
0.9% saline group (p = 0.7). The lowest exit [Na] (133
mmol/L) and maximum rate of fall (-0.52 mmol/L/h)
were in a surgical patient receiving 0.45% saline; this
patient had 380 ml of oral fluid intake during the study
interval. The second lowest exit [Na] (135 mmol/L) and
next fastest rate of fall (-0.40 mmol/L/h) were in a med-
ical patient receiving 0.9% saline; oral intake was 82 ml.
There were no adverse events. No participant devel-
oped hypertension. A 6 year-old boy with gastroenteritis
in the 0.9% saline group developed mild hypernatremia,
with an exit [Na] of 147 mmol/L.
Stratified analysis
Fluid management differed between medical and surgical
patients. Therefore, although numbers were small, an
exploratory analysis, stratified by admission type, was also
conducted. Medical patients received the study fluid at
142% [IQR 118, 150] of the traditional maintenance rate,
and 19.7 ml/kg [IQR 14.7, 20.8] of additional isotonic
fluids, mostly in the form of boluses. In contrast, surgical
patients received study fluid at 101% [IQR 94, 108] of the
traditional maintenance rate, and received only 3.4 ml/kg
[IQR 2.6, 8.7] of additional isotonic fluids. The duration
and rate of study fluid administration, and volume of addi-
tional isotonic fluids were similar for the 0.9% and 0.45%
saline groups overall. The changes in [Na] observed when
medical and surgical patients were analyzed separately
mirrored those in the unstratified analysis.
 
Assessed for eligibility (n=142 ) 
Declined to participate (n=83) 
Analysed  (n=16) 
Lost to follow-up (n=8) 
 Did not complete 8 h (n=2) 
 Consent withdrawn (n=1) 
  Exit [Na] not obtained (n=5) 
Allocated to 0.9% saline (n=27)  
 Received allocated intervention (n=24)  
 Ineligible: baseline [Na] < 133 mmol/L (n=3) 
Lost to follow-up (n=11) 
 Did not complete 8 h (n=6) 
 Consent withdrawn (n=2) 
   Exit [Na] not obtained (n=3) 
Allocated to 0.45% saline (n=32) 
 Received allocated intervention (n=32) 
 
Analysed  (n=21) 
Randomized (n=59)               
(Surgical n=34 Medical n=25) 
Figure 1 Flow diagram of patients invited to participate. For practical reasons it was necessary to randomize patients before eligibility was
confirmed. Study fluid was often started while awaiting the results of the baseline [Na]– which was used to determine eligibility. It was not
always possible to predict which patients would require at least 8 hours of study fluid. Eight medical patients were withdrawn from the study
(no exit [Na] obtained) when IV fluids were discontinued prior to completion of 8 hours of study fluid.
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Contrary to our expectations, we observed increases in
serum sodium in both the 0.45% and 0.9% groups,
although this change was only statistically significant in
the 0.9% group. Furthermore, similar proportions of indi-
viduals in both treatment arms developed hyponatremia.
After decades of using hypotonic fluids, the best choice
of solution for maintenance IV fluid therapy has recently
become a topic of intense debate. Six randomized trials
favored isotonic over hypotonic fluids for the prevention
of hyponatremia [25,27-31]. There were two main differ-
ences between the present trial and past studies. First,
the present study included a more diverse population
than past trials, including both non-critically ill general
medical patients and surgical patients after completion of
surgery. Second, prior trials dictated both the rate and
composition of fluids administered. A strength of the
present study is that only fluid composition was dictated
by study protocol; physician sw e r ea d v i s e dt h a ts t u d y
fluid was to be used for maintenance needs, and allowed
the freedom to choose the rate of administration and any
additional fluids according to their usual practice. This
allowed us to isolate the impact of fluid composition
on changes in serum [Na] in a ‘real world’ clinical setting
in which physicians determined the rate of fluid
administration.
Maintenance fluids are one of the three key compo-
nents of an IV fluid prescription, along with deficit repla-
cement, and replacement of ongoing losses [33]. The goal
of maintenance fluids is to maintain fluid homeostasis by
replacing both insensible water losses and obligate urin-
ary water losses. Combining theoretical considerations
regarding obligate urinary water losses, empiric estimates
of average daily insensible water losses, and estimates of
daily electrolyte requirements, Holliday and Segar recom-
mended hypotonic solutions (0.2% saline) for the mainte-
nance component of the IV fluid prescription [1].
However, their assumptions regarding obligate urinary
water losses - or at least regulation of urinary water
losses -may not be valid among hospitalized children.
Recommendations for replacement of a volume deficit
vary. For rapid volume expansion, only isotonic fluids are
considered safe and effective [34]. Although some sources
suggest that 0.45% saline can be used for slow correction
of volume deficits [35], use of 0.45% saline in a volume
depleted patient (who therefore has elevated ADH) will
predictably lead to a drop in serum [Na]. Volume deficits
Table 1 Participant characteristics
0.9% saline 0.45% saline
n1 6 2 1
Age (y), median [IQR] 8.2 [2.8, 14.3] 8.9 [1.7, 16.5]
Males (n) (%) 8 (50) 10 (48)
Diagnosis
Medical (total) (%) 6 (38) 6 (29)
Gastroenteritis 4 (25) 5 (24)
Pneumonia 1 (6) 1 (5)
Other 1 (6) 0 (0)
Surgical (total) (%) 10 (62) 15 (71)
Bowel surgery 2 (13) 3 (14)
Orthopedic surgery 5 (31) 8 (38)
Other 3 (19) 4 (19)
Baseline [Na] (mmol/L) median [IQR] 138 [135.5, 139] 137 [135,138]
IQR, interquartile range.
Table 2 Fluids Administered and [Na] changes
0.9% saline 0.45% saline P-value*
Fluid Administration (median [IQR])
Hours of study fluid administration 12 [10, 12.7] 11.9 [11.6, 12.3] 0.97
Rate (as % traditional maintenance rate) 105 [95,141] 104 [99,123] 0.80
Additional isotonic fluids (ml/kg) 7.4 [3.4, 18.6] 8.6 [2.8, 19.3] 0.84
Oral fluids (ml/kg) 4.7 [0.2, 8.3] 0 [0,6] 0.14
Free water (ml/kg) 4.7 [0.7, 8.3] 16.5 [12, 29.5] 0.00
Free water (% of total fluids received) 12 [1,20] 45 [37,64] 0.00
[Na] Data (median [IQR])
Rate of change [Na] (mmol/L/hr) +0.20 [0.03, 0.4] +0.08 [-0.15, 0.16] 0.12
Absolute change in [Na] (mmol/L) +3.0 [0.5, 4.5] +1.0 [0.0, 2.0] 0.14
Exit [Na] (mmol/L) 140 [138,141] 138 [136,139] 0.10
[Na] Data (number (%))
No. of patients with a fall in [Na] (%) 3 (19) 5 (24) 0.7
No. of patients with exit Na < 136 mmol/L (%) 1 (6) 1 (5) 1
*P-values for continuous variables were determined using 2-sided (Wilcoxon) rank sum tests
P-values for categorical variables were determined using Chi-square tests
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fluid. This view is reflected in current recommendations
[32,34]. The composition of fluid used for ongoing losses
depends on the type of fluid being lost.
Regardless of the recommendation to consider deficit
replacement separately from maintenance fluid needs, it
has been common practice to simply increase the rate
of infusion of the maintenance fluid solution to “1.5
times or 2 times maintenance” in an effort to replace
volume deficits that remain after bolus isotonic fluids
have been given for rapid intravascular volume expan-
sion. This practice was evident among the medical
patients participating in the present study, who received
study fluid at an average of 142% of the traditional
Figure 2 Changes in serum [Na] in patients receiving 0.9% saline (a) and 0.45% saline (b). Each line represents an individual patient.
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of differing maintenance fluid composition on [Na] in
the context of current prescription practices.
As expected, we observed a significant increase in
serum [Na] among patients in the 0.9% saline group. A
smaller and slower, though not statistically significant,
increase in [Na] was observed in the 0.45% saline group.
This was not anticipated. Rather, we had hypothesized
that patients randomized to receive hypotonic fluids
would experience a drop in serum [Na]. The rationale for
this hypothesis was that the patients enrolled in the study
were at risk for high ADH secretion, stimulated by either
volume depletion (appropriately) or the syndrome of
inappropriate ADH secretion (due to pain, medications,
pulmonary disease, etc.). Because free water excretion is
impaired in the presence of ADH, the administration of
hypotonic solutions to patients secreting ADH will inevi-
tably lead to a fall in serum [Na] [10].
The fact that most children who received 0.45% saline
did not experience a drop in [Na] suggests that most did
not have an ongoing stimulus for ADH secretion. Ade-
quate volume repletion with isotonic fluids prior to and
during IV maintenance fluid administration likely pro-
tected patients against hyponatremia despite hypotonic
maintenance fluids. Those who did experience a drop in
[Na] can be assumed either to have not been adequately
volume expanded (and therefore have ongoing physiolo-
gic volume-related stimulus for ADH secretion) or to
have had inappropriate ADH secretion (non-physiologic,
unpredictable ADH secretion). Children in the 0.9%
saline group who experienced a decrease in [Na] were
very likely to have had inappropriate ADH secretion;
unless they developed new onset adrenal insufficiency,
hypothyroidism, or renal salt wasting, inappropriate
ADH secretion is the only reasonable explanation for a
drop in [Na] in this group [25,36].
The average rate of study fluid administration in both
treatment groups was only slightly greater than the tradi-
tionally recommended maintenance rate. This likely also
played a role in the relative stability in serum [Na]. Hypo-
tonic fluids prescribed at high rates have been implicated
in many of the reported deaths due to iatrogenic hypona-
tremia [19].
Two features of the study design may have resulted in
bias toward finding no difference between treatment
groups. First, the exclusion for safety reasons of children
with baseline [Na] < 133 mmol/L or serious neurological
disease may have eliminated those children at the highest
risk for progressive hyponat r e m i a .S e c o n d ,t h i ss t u d y
focused on the first 12 hours of maintenance fluids. This
was done in part for practical reasons, but also because
we hypothesized that more pain and a greater degree of
volume depletion would make this early period the per-
iod of highest risk for non-osmotic stimuli for ADH
secretion. However, the syndrome of inappropriate ADH
secretion may occur at any time, and may be more likely
to occur later in the hospitalization, particularly in surgi-
cal patients [10,27]. If the risk of inappropriately elevated
ADH increases with increasing duration of hospitaliza-
tion, then evaluating only the first 12 hours of IV fluids
may have biased towards finding no difference between
the groups.
This was a small trial. The small sample limited our abil-
ity to detect small differences between the two treatment
groups. It is possible that both the observed difference
between treatment groups and the change in [Na] in the
0.45% saline group would have been statistically significant
with a larger sample. The relatively large proportion of
patients who failed to complete the study was an addi-
tional limitation. There were some differences in the char-
acteristics of patients who completed the study compared
with those who did not. This may limit generalizability of
findings.
It is also important to recognize that this study was
designed to examine intermediate outcomes (rate of
change in [Na], absolute change in [Na], exit [Na]) rather
than a clinically important outcome (complications asso-
ciated with choice of fluid). This was done for power rea-
sons: clinical complications are rare and would require a
very large sample. Complications of hyponatremia are
believed to depend on both the magnitude of the serum
[Na] and the rate of change; therefore, these were consid-
ered relevant outcomes. However, much larger trials,
examining clinically important outcomes, are required to
establish the safety of different maintenance fluids.
The most important finding of this study was that there
was no decrease in [Na] in the 0.45% saline group; this
can likely be attributed to judicious use of volume expan-
sion with isotonic fluids and to the fact that, in most
patients, study fluids were prescribed at rates generally
not exceeding traditional maintenance rates. This result
highlights the importance of considering maintenance
fluids separately from deficit replacement.
It is important to recognize that there is no IV fluid
strategy that will completely eliminate the risk of iatro-
genic hyponatremia. Hypotonic fluids in the setting of
subtle, unrecognized volume depletion will result in a
drop in [Na]. In the setting of the syndrome of inappropri-
ate ADH secretion, [Na] may fall even with isotonic fluids
- although larger drops will occur with hypotonic fluids.
The use of isotonic fluids may reduce the risk of important
hyponatremia, but if tragic consequences of IV fluids are
to be avoided, monitoring of serum [Na] is important.
Conclusion
Firm conclusions regarding the best solution for mainte-
nance IV fluids cannot be drawn from this small study.
Larger studies, powered to detect differences in the
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symptomatic hyponatremia or hypernatremia and hyper-
tension, in addition to differences in change in [Na],
are needed. In addition, studies of longer duration
would be useful. This study suggests that 0.45% saline
does not result in a drop in [Na] during the first 12
hours of fluid therapy among children with a baseline
[Na] > 133 mmol/L and < 145 mmol/L, if appropriate
care is taken to restore volume deficits with isotonic
fluids, and excessive fluid administration rates are
avoided. However, confirmation of these results in a lar-
ger study is strongly recommended.
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